Cubation with LBH589 that was abolished by C646 treatment. Accordingly, enhanced CREB binding to NKG2D-L
Cubation with LBH589 that was abolished by C646 treatment. Accordingly, enhanced CREB binding to NKG2D-L promoter regions was identified by chromatin immunoprecipitation (Figure 5b). This was in line using the…